Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT)

Historical Holders from Q3 2016 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
FLGT on Nasdaq
Shares outstanding
30,210,911
Price per share
$26.27
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
17,228,107
Total reported value
$389,318,961
% of total 13F portfolios
0%
Share change
+914,837
Value change
+$21,532,521
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
162
Price from insider filings
$28.33
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BARCLAYS PLC 7.6% +43% $42,396,117 +$12,335,507 2,338,451 +41% Barclays PLC 31 Mar 2025
BlackRock, Inc. 5.9% $32,993,391 1,819,823 BlackRock, Inc. 31 Mar 2025
MILLENNIUM MANAGEMENT LLC 5.6% +18% $33,633,203 +$4,961,034 1,691,811 +17% Millennium Management LLC 22 Jul 2025
As of 30 Sep 2025, Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) has 162 institutional shareholders filing 13F forms. They hold 17,228,107 shares. of 30,210,911 outstanding shares (57%) .

Top 25 institutional shareholders own 47% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BlackRock, Inc. 9.8% 2,975,411 +38% 0% $67,244,288
MILLENNIUM MANAGEMENT LLC 4.9% 1,468,844 +1.8% 0.03% $33,195,874
VANGUARD GROUP INC 3.9% 1,179,254 +1.1% 0% $26,651,141
ACADIAN ASSET MANAGEMENT LLC 3.8% 1,140,163 +2% 0.04% $25,754,000
DIMENSIONAL FUND ADVISORS LP 3.8% 1,133,103 -0.12% 0.01% $25,607,425
D. E. Shaw & Co., Inc. 1.9% 567,770 +19% 0.01% $12,831,602
DEUTSCHE BANK AG\ 1.7% 504,485 +52% 0% $11,401,361
STATE STREET CORP 1.7% 501,996 -2.3% 0% $11,345,110
GEODE CAPITAL MANAGEMENT, LLC 1.7% 501,671 -2.3% 0% $11,339,902
AMERIPRISE FINANCIAL INC 1.6% 494,953 -0.69% 0% $11,185,938
CITADEL ADVISORS LLC 1.2% 371,476 -38% 0.01% $8,395,357
Point72 Asset Management, L.P. 1.2% 371,261 -32% 0.02% $8,390,505
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.2% 359,281 +20% 0% $8,119,751
Connor, Clark & Lunn Investment Management Ltd. 1.1% 331,526 +8.6% 0.02% $7,492,488
JPMORGAN CHASE & CO 0.99% 299,014 +767% 0% $6,757,717
Nuveen, LLC 0.96% 290,853 -5.8% 0% $6,573,278
MORGAN STANLEY 0.92% 276,558 +23% 0% $6,250,214
Diametric Capital, LP 0.8% 241,622 +43% 2% $5,460,657
NORTHERN TRUST CORP 0.66% 200,826 +0.2% 0% $4,538,668
GOLDMAN SACHS GROUP INC 0.61% 183,998 +58% 0% $4,158,355
BARCLAYS PLC 0.59% 178,867 -9.5% 0% $4,042,394
Trexquant Investment LP 0.57% 172,372 +42% 0.04% $3,895,607
TUDOR INVESTMENT CORP ET AL 0.57% 171,495 -7.3% 0.03% $3,875,787
Peapod Lane Capital LLC 0.54% 164,579 +1.1% 3.3% $3,719,789
TWO SIGMA INVESTMENTS, LP 0.52% 157,608 +68% 0.01% $3,561,941

Institutional Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 25,255 $663,603 -$20,603 2,626.99% 4
2025 Q3 17,228,107 $389,318,961 +$21,532,521 2,260% 162
2025 Q2 16,260,263 $323,227,753 +$1,152,439 1,988% 165
2025 Q1 16,317,307 $275,768,406 -$14,217,098 1,690% 173
2024 Q4 17,016,195 $314,285,279 +$12,985,883 1,847% 185
2024 Q3 16,092,056 $349,642,907 +$18,556,959 2,173% 181
2024 Q2 15,271,785 $299,655,107 +$9,367,412 1,962% 170
2024 Q1 14,727,786 $319,564,135 +$6,539,138 2,170% 177
2023 Q4 14,302,809 $413,495,913 +$4,547,542 2,891% 193
2023 Q3 14,229,204 $380,479,266 +$6,537,668 2,674% 196
2023 Q2 13,900,018 $514,629,091 +$13,570,378 3,703% 210
2023 Q1 13,537,003 $422,618,519 +$14,324,645 3,122% 213
2022 Q4 13,130,080 $391,069,830 -$9,588,373 2,978% 218
2022 Q3 13,298,290 $506,859,271 -$7,820,533 3,811.91% 217
2022 Q2 12,997,411 $708,963,224 +$53,955,153 5,453.04% 247
2022 Q1 12,047,292 $751,600,750 +$40,161,746 6,240.66% 263
2021 Q4 11,205,792 $1,127,293,672 -$26,292,784 10,058.83% 284
2021 Q3 11,367,430 $1,022,253,660 +$64,809,061 8,995.03% 258
2021 Q2 10,632,791 $980,578,944 +$54,311,867 9,222.96% 246
2021 Q1 10,008,047 $966,031,706 +$64,885,192 9,661.9% 243
2020 Q4 9,615,937 $501,565,082 +$82,198,208 5,209.96% 184
2020 Q3 8,084,326 $323,850,761 +$79,786,110 4,003.96% 122
2020 Q2 6,322,946 $101,163,272 +$14,541,369 1,600% 81
2020 Q1 6,111,180 $65,545,855 +$3,544,598 1,075.97% 72
2019 Q4 5,668,534 $73,105,675 +$35,387,759 1,289.92% 70
2019 Q3 2,927,084 $30,408,049 +$16,888,791 1,038.95% 33
2019 Q2 1,301,144 $8,691,007 +$411,415 667.95% 12
2019 Q1 1,242,460 $7,393,006 +$220,569 595.16% 15
2018 Q4 1,210,059 $3,835,003 -$982,557 316.83% 13
2018 Q3 1,458,250 $5,731,004 +$22,470 393.09% 15
2018 Q2 1,452,436 $6,013,004 +$11,608 413.9% 15
2018 Q1 1,449,767 $5,789,004 +$112,502 399.42% 18
2017 Q4 1,415,208 $6,199,004 -$6,549,628 438.02% 16
2017 Q3 2,390,312 $11,378,005 -$4,107,706 478.92% 19
2017 Q2 2,976,441 $19,019,006 -$5,819,346 638.88% 20
2017 Q1 3,492,074 $38,134,153 +$4,840,117 1,091.98% 35
2016 Q4 3,066,506 $35,477,491 +$5,733,496 1,157.04% 36
2016 Q3 2,647,726 $24,413,000 +$24,413,000 922% 16